Veterinary Medicines

Kaltetan forte, 458.4 mg/ml + 125 mg/ml + 20 mg/ml solution for infusion for horses, cattle and pigs

Authorised
  • CALCIUM GLUCONATE FOR INJECTION
  • Magnesiumchlorid-Hexahydrat
  • Dinātrija-1-glicerofosfāta pentahidrāts
Download as PDF

Auðkenning lyfsins

Heiti lyfs:
Kaltetan forte, 458.4 mg/ml + 125 mg/ml + 20 mg/ml solution for infusion for horses, cattle and pigs
Калтетан форте, 458,4 mg/ml + 125 mg/ml + 20 mg/ml инфузионен разтвор за коне
Virkt efni:
Dýrategundir:
  • Hestur
  • Nautgripir
  • Svín
Íkomuleið:
  • Til notkunar í bláæð

Upplýsingar um lyfið

Virkt efni / Styrkur:
  • Aðeins í boði í English
    458.40
    milligram(s)
    /
    1.00
    millilitre(s)
  • Aðeins í boði í English
    125.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Aðeins í boði í English
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Lyfjaform:
  • Innrennslislyf, lausn
Withdrawal period by route of administration:
  • Intravenous use
    • Hestur
      • Mjólk
        5
        week
    • Nautgripir
      • Kjöt og innmatur
        5
        week
    • Svín
      • Kjöt og innmatur
        5
        week
ATC flokkun (dýralyf):
  • QA12AX
Lögformleg staða:
Staða markaðsleyfis:
  • Gilt
Authorised in:
  • Búlgaría
Available in:
  • Búlgaría
Áletrun:

Viðbótarupplýsingar

Entitlement type:
  • Markaðsleyfi
Lagagrundvöllur vöruleyfis:
Markaðsleyfishafi:
  • Vet-Agro Multi-Trade Company Sp. z o.o.
Markaðsleyfi gefið út:
Framleiðandi sem ber ábyrgð á lokasamþykkt:
  • Multi-Trade Company "Vet-Agro" Sp. z o.o.
Útgáfuland markaðsleyfis:
  • Búlgaría
Ábyrgt yfirvald:
  • Bulgarian Agency For Food Safety
Markaðsleyfisnúmer:
  • 0022-3110
Dagsetning leyfisbreytingar:
Umsjónarland (RMS):
  • Pólland
Númer verkferlis:
  • PL/V/0110/002
Þátttökulönd (CMS):
  • Búlgaría
  • Tékkland
  • Grikkland
  • Ungverjaland
  • Ítalía
  • Litáen
  • Portúgal
  • Rúmenía
  • Spánn

Skjöl

Samantekt á eiginleikum lyfs

Published:
Bulgarian (PDF)
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."